TCL Archive IOM Panel: NCI Clinical Trials Groups At “Breaking Point,” More Funds Needed. April 16, 2010
TCL Archive White House Plans to Name Broder NCI Director, Overruling Wyngaarden, Who Support Rabson December 2, 1988
TCL Archive Avastin Vote Puts Focus On FDA Criteria In First-Line Metastatic Breast Cancer: Is PFS Good Enough? December 14, 2007
